Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

The use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria.

Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases

Cardiovascular diseases, including stroke and myocardial infarction, are the world’s leading causes of mortality, accounting for over 18 million deaths a year.

April 18, 2024

Mobile Pay Revolutionizes Specialty Groups: Unlock the Data-Driven Potential

Janet Carbary, CFO of Integrated Rehab Group It’s no surprise that healthcare is doubling down on software investments for healthcare revenue cycle, including software with an AI

November 20, 2023

Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year – Biotech Investments

Eckert & Ziegler SE / Key word(s): 9 Month figures/Preliminary Results Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.